Progetti del bando aggiuntivo - a.a. 2023/2024 (D.R. 8484 8/11/2023)

Di seguito è possibile visualizzare l’elenco dei Supervisori e dei progetti presentati, suddivisi per curriculum, per il bando di concorso aggiuntivo per l'ammissione al Corso di Dottorato in Medicina Molecolare per l'a.a. 2023/2024 (D.R. 8484 del 8 novembre 2023).

IMMUNOLOGIA E ONCOLOGIA DI BASE E APPLICATE

4 Borse a progetto

BAIO1: FALLETTA PAOLA

Unit: Experimental Imaging Center  – IRCCS Ospedale San Raffaele

Finanziata su fondi riportati ai sensi del D.D. 6 giugno 2022 n. 931

BAIO1: Dissecting Integrated Stress Response-driven metastatic potential and drug resistance in patient-derived models of colorectal cancer

BAIO2: CASORATI GIULIA

Unit: Experimental immunology – IRCCS Ospedale San Raffaele

BAIO2: Harnessing T and iNKT cells with CD1 restricted TCRs for adoptive immunotherapy of leukemia

BAIO3: DEGANO MASSIMO

Unit: Biocrystallography – IRCCS Ospedale San Raffaele

BAIO3: Molecular basis of B-cell receptor cell-autonomous signalling in chronic lymphocytic leukemia

BAIO4: EMANUELA FINA

Unit: Thoracic Surgery – IRCCS Ospedale San Raffaele

BAIO4: Therapy-induced transcriptional changes and metastatic ability of single circulating tumor cells (CTCs) and CTC clusters in breast cancer

MEDICINA CLINICA E SPERIMENTALE

2 Borse a progetto

ECM1: DE COBELLI FRANCESCO

Unit: Radiology – IRCCS Ospedale San Raffaele

Finanziata su fondi ripartiti ai sensi del D.D. 6 giugno 2022 n. 931

ECM1: Improving diagnosis, monitoring and treatment in cancer patients through artificial Intelligence predictive models

ECM2: ORESTE DAVIDE GENTILINI

Unit: Breast Surgery - IRCCS Ospedale San Raffaele

ECM2: Circulating tumor cell longitudinal monitoring as a non-invasive test for relapse risk scoring in patients with operable breast cancer

NEUROSCIENZE E NEUROLOGIA SPERIMENTALE

2 Borse a progetto

NEN1: FARINA CINTHIA

Unit: Immunobiology of Neurological Disorders – IRCCS Ospedale San Raffaele

NEN1: Systems Immunology in Neurological Disorders

NEN2: BOLINO ALESSANDRA

Unit: Human Inherited Neuropathies

NEN2: AAV-mediated gene therapy to treat inherited neuropathies with aberrant myelin

TERAPIA GENICA E CELLULARE

3 Borse a progetto

GCT1: BONINI CHIARA

Unit: Experimental Hematology Unit

GCT1: Patient-derived Treg manufacturing for adoptive Treg therapy

GCT2: GREGORI SILVIA

Unit: Mechanisms of Peripheral Tolerance

GCT2: Unravelling the molecular mechanisms underlying IL-10 induced tolerogenic features in human dendritic cells

GCT3: GRITTI ANGELA

Unit: SR-Tiget, Unit of gene/neural stem cell therapy for lysosomal storage diseases

GCT3: To model and study mechanisms of disease and disease correction in clinically-relevant gene therapy settings using hiPSC-based 2D/3D in vitro platforms